- Home
- IMTE vs NCNA Comparison
IMTE vs NCNA Comparison
Compare IMTE & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- NCNA
- Stock Information
- Founded
- IMTE 2008
- NCNA 1997
- Country
- IMTE Malaysia
- NCNA United Kingdom
- Employees
- IMTE N/A
- NCNA N/A
- Industry
- IMTE Consumer Electronics/Appliances
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- NCNA Health Care
- Exchange
- IMTE Nasdaq
- NCNA Nasdaq
- Market Cap
- IMTE 4.2M
- NCNA 4.4M
- IPO Year
- IMTE N/A
- NCNA 2017
- Fundamental
- Price
- IMTE $1.27
- NCNA $1.29
- Analyst Decision
- IMTE
- NCNA Buy
- Analyst Count
- IMTE 0
- NCNA 2
- Target Price
- IMTE N/A
- NCNA $25.00
- AVG Volume (30 Days)
- IMTE 22.1K
- NCNA 99.0K
- Earning Date
- IMTE 12-27-2024
- NCNA 11-25-2024
- Dividend Yield
- IMTE N/A
- NCNA N/A
- EPS Growth
- IMTE N/A
- NCNA N/A
- EPS
- IMTE N/A
- NCNA N/A
- Revenue
- IMTE $383,813.00
- NCNA N/A
- Revenue This Year
- IMTE N/A
- NCNA N/A
- Revenue Next Year
- IMTE N/A
- NCNA N/A
- P/E Ratio
- IMTE N/A
- NCNA N/A
- Revenue Growth
- IMTE 4.75
- NCNA N/A
- 52 Week Low
- IMTE $1.06
- NCNA $1.20
- 52 Week High
- IMTE $3.84
- NCNA $19.40
- Technical
- Relative Strength Index (RSI)
- IMTE 43.83
- NCNA 38.62
- Support Level
- IMTE $1.21
- NCNA $1.23
- Resistance Level
- IMTE $1.29
- NCNA $1.39
- Average True Range (ATR)
- IMTE 0.13
- NCNA 0.06
- MACD
- IMTE -0.01
- NCNA 0.03
- Stochastic Oscillator
- IMTE 11.63
- NCNA 37.05
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.